Gerardo Alvarez-Uria

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 7

Top Topics

Antimicrobial Resistance

Hiv Infected Patients

Mycobacterium Tuberculosis

Methicillin Resistant Staphylococcus Aureus

Top Venues

Antibiotics (Basel, Switzerland)

Journal of pathogens

Therapeutic advances in infectious disease

The European respiratory journal

This page only lists publications with an associated author ORCID identifier.

Publications

Sumanth Gandra, Gerardo Alvarez-Uria, Dustin Stwalley, Katelin B Nickel, Kimberly A Reske, Jennie H Kwon, Erik R Dubberke, Margaret A Olsen, Jason P Burnham
Microbiology Clinical Culture Diagnostic Yields and Antimicrobial Resistance Proportions before and during the COVID-19 Pandemic in an Indian Community Hospital and Two US Community Hospitals. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Sumanth Gandra, Gerardo Alvarez-Uria, Dustin Stwalley, Katelin B Nickel, Kimberly A Reske, Jennie H Kwon, Erik R Dubberke, Margaret A Olsen, Jason P Burnham
Microbiology Clinical Culture Diagnostic Yields and Antimicrobial Resistance Proportions before and during the COVID-19 Pandemic in an Indian Community Hospital and Two US Community Hospitals. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Gerardo Alvarez-Uria, Sumanth Gandra, Venkata R Gurram, Raghu P Reddy, Manoranjan Midde, Praveen Kumar, Ketty E Arce
Development and Validation of the RCOS Prognostic Index: A Bedside Multivariable Logistic Regression Model to Predict Hypoxaemia or Death in Patients with SARS-CoV-2 Infection. Interdisciplinary perspectives on infectious diseases 2022 (2022)
Gerardo Alvarez-Uria, Manoranjan Midde, Jayaram Battula, Himachandra N B Pujari
Safety and tolerability of intrathecal liposomal amphotericin B (AmBisome) for cryptococcal meningitis: a retrospective study in HIV-infected patients. Therapeutic advances in infectious disease 5 (5) (2018)
Gerardo Alvarez-Uria, Manoranjan Midde
Sex differences and factors influencing the duration of the QT interval in patients on anti-tuberculosis therapy. The European respiratory journal 51 (2) (2018)
Sumanth Gandra, Sanjeev K Singh, Dasaratha R Jinka, Ravishankar Kanithi, Ashok K Chikkappa, Anita Sharma, Dhanya Dharmapalan, Anil Kumar Vasudevan, Onkaraiah Tunga, Akhila Akula, Garima Garg, Yingfen Hsia, Srinivas Murki, Gerardo Alvarez-Uria, Mike Sharland, Ramanan Laxminarayan
Point Prevalence Surveys of Antimicrobial Use among Hospitalized Children in Six Hospitals in India in 2016. Antibiotics (Basel, Switzerland) 6 (3) (2017)
Raghuprakash Reddy, Gerardo Alvarez-Uria
Molecular Epidemiology of Rifampicin Resistance in Mycobacterium tuberculosis Using the GeneXpert MTB/RIF Assay from a Rural Setting in India. Journal of pathogens 2017 (2017)
Gerardo Alvarez-Uria, Raghavakalyan Pakam, Manoranjan Midde, Praveen Kumar Naik
Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines. International scholarly research notices 2014 (2014)
Gerardo Alvarez-Uria, Praveen K Naik, Manoranjan Midde, Pradeep S Yalla, Raghavakalyan Pakam
Prevalence and severity of anaemia stratified by age and gender in rural India. Anemia 2014 (2014)